Acasti Pharma Inc EV/Sales
Qual é o EV/Sales de Acasti Pharma Inc?
O EV/Sales de Acasti Pharma Inc é N/A
Qual é a definição de EV/Sales?
Enterprise value to sales ratio compares a company’s total value to its sales.
ttm (trailing twelve months)
Enterprise value/sales is a valuation ratio that compares the company's enterprise value to its annual sales. It indicates the company's capacity to generate free cash flow. In general, the lower the ratio, the cheaper the company is.
EV/Sales is most often calculated as cash and cash equivalents subtracted from the sum of market capitalization and debt and divided by annual sales. Many analysts consider EV/sales to be a more accurate metric than Price/Sales as it considers both debt and equity holders in its calculation. One of the limitations of the calculation is that sales do not take into account a company's taxes or expenses.
EV/Sales de empresas na Setor Health Care em NASDAQ em comparação com Acasti Pharma Inc
O que Acasti Pharma Inc faz?
acasti pharma, inc., a subsiduary of neptune technologies & bioressources, is a quebec-based biopharmaceutical dedicated in advancing a proprietary portfolio based on marine phospholipids. our products can be used in prescription, medical food and over-the-counter applications, either as a stand-alone, or, as a fixed-dose combination to exisitng productrs, for the prevention and treatment of cardiometabolic disorders.
Empresas com ev/sales semelhantes a Acasti Pharma Inc
- Leap Therapeutics Inc tem EV/Sales de N/A
- Strike tem EV/Sales de N/A
- VYNE Therapeutics tem EV/Sales de N/A
- Tissue Repair Ltd tem EV/Sales de N/A
- Catheter Precision tem EV/Sales de N/A
- Mirasol Resources tem EV/Sales de N/A
- Acasti Pharma Inc tem EV/Sales de N/A
- Pembroke Venture Capital Trust tem EV/Sales de N/A
- Maven Income & Growth VCT tem EV/Sales de N/A
- Ayala Pharmaceuticals tem EV/Sales de N/A
- Yatra Capital tem EV/Sales de N/A
- SREI Infrastructure Finance tem EV/Sales de N/A
- Aquarius AI tem EV/Sales de N/A